Vinati Organics

A strange thing to name after your child

Most fathers name a daughter's school, maybe a trust, after her. In 1989, Vinod Saraf named a chemicals company.

He was 40, on a clean CEO track, and he walked away from it to start something of his own in Mumbai. Not a consumer brand. Not anything you'd recognise. He picked two industrial chemicals with names that make your eyes glaze over — IBB, which goes into ibuprofen, and ATBS, which quietly does its job inside oil drilling and water treatment.

Nobody in India wanted to make these. That was exactly the point.

Seventeen quiet years

There is no dramatic montage here. For seventeen years, Vinod Saraf simply built. No glamour, no advertising, no big-bang launch. Just obsessive quality and one global customer relationship at a time — the kind of work that doesn't trend but compounds.

He was learning a lesson that the loud parts of business often miss: in chemicals, trust is the product. A buyer who depends on your molecule for their own factory does not switch suppliers on a whim. Every clean batch you ship is a small deposit into a relationship that can last decades.

The daughter comes home

Then, in 2006, Vinati Saraf Mutreja came back from Wharton.

She looked at what her father had patiently assembled and asked the question that changes companies: why aren't we scaling this harder?

It's one thing to build something solid. It's another to look at solid and see a launchpad. She pushed for aggressive expansion of ATBS capacity — making more of the thing the world had quietly started to need.

And here's where it gets beautiful. As Vinati made more ATBS, global buyers began consolidating their purchases around it. The more they bought, the higher their switching costs climbed. Every passing year made the company a little more irreplaceable. By the early 2010s, Vinati Organics had crossed a threshold very few Indian companies ever reach: it wasn't competing in a market, it was the market.

What the company is today

Today, Vinati Organics Limited controls roughly 65% of the global ATBS market. Not 65% of India — 65% of the world.

Revenue for FY2025 came in at ₹2,248 crore, with exports reaching more than 30 countries. The market capitalisation sits around ₹13,800 crore. And with global supply chains actively trying to move away from China, a company that already makes a niche chemical better than almost anyone else suddenly looks less like a quiet operator and more like strategic infrastructure.

The lesson hiding in the name

There's a temptation to read this as a story about chemistry. It isn't. It's a story about two kinds of building.

The father's kind is patient, unglamorous, allergic to shortcuts — the slow accumulation of quality and trust that creates something real. The daughter's kind is the courage to take something real and refuse to let it stay small.

Most companies have one and not the other. Vinati Organics had both, in sequence, in the same family. He built the moat. She built the castle. And the company still carries her name.